United Therapeutics
UTHR
UTHR
820 hedge funds and large institutions have $20.2B invested in United Therapeutics in 2025 Q4 according to their latest regulatory filings, with 192 funds opening new positions, 276 increasing their positions, 257 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.26% more ownership
Funds ownership: 90.67% → 96.93% (+6.3%)
7% more repeat investments, than reductions
Existing positions increased: 276 | Existing positions reduced: 257
6% less funds holding in top 10
Funds holding in top 10: 17 → 16 (-1)
Holders
820
Holding in Top 10
16
Calls
$390M
Puts
$352M
Top Buyers
| 1 | +$486M | |
| 2 | +$272M | |
| 3 | +$159M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$150M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$137M |
Top Sellers
| 1 | -$318M | |
| 2 | -$171M | |
| 3 | -$130M | |
| 4 |
Renaissance Technologies
New York
|
-$123M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$113M |
